Literature DB >> 20646987

Clinical and immunologic predictors of influenza illness among vaccinated older adults.

Zainab Shahid1, Alison Kleppinger, Beth Gentleman, Ann R Falsey, Janet E McElhaney.   

Abstract

The diagnosis of influenza is often missed in older adults and illness presentation may be modified by prior vaccination. We evaluated the symptoms and immunologic markers predicting laboratory-confirmed influenza (LCI) among vaccinated older adults. In subjects with influenza-like illness (ILI), fever distinguished subjects with laboratory-confirmed influenza (LCI) from those with other ILI (39% vs. 12.5%, p=0.009). In LCI subjects who did not seroconvert to influenza infection, pre-infection levels of the cytolytic mediator, granzyme B, correlated with fever (r=1.000; p=0.01) and the IFN-gamma:IL-10 ratio (r=0.999; p=0.03), and increased following influenza infection in LCI vs. ILI subjects (p=0.03). The cell-mediated immune response to influenza distinguishes A/H3N2 LCI from other ILI in older adults, and suggests a link between cell-mediated immunity and influenza illness severity in vaccinated older adults. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646987      PMCID: PMC2948951          DOI: 10.1016/j.vaccine.2010.07.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

Review 1.  Serious morbidity and mortality associated with influenza epidemics.

Authors:  W P Glezen
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

2.  Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice.

Authors:  L J van Elden; G A van Essen; C A Boucher; A M van Loon; M Nijhuis; P Schipper; T J Verheij; I M Hoepelman
Journal:  Br J Gen Pract       Date:  2001-08       Impact factor: 5.386

3.  The predictive value of influenza symptomatology in elderly people.

Authors:  T M Govaert; G J Dinant; K Aretz; J A Knottnerus
Journal:  Fam Pract       Date:  1998-02       Impact factor: 2.267

4.  Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.

Authors:  Barbara J Johnson; Elaine O Costelloe; David R Fitzpatrick; John B A G Haanen; Ton N M Schumacher; Lorena E Brown; Anne Kelso
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

5.  A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B.

Authors:  Catherine Ewen; Kevin P Kane; Irene Shostak; Philip J Griebel; Edward M Bertram; Tania H Watts; R C Bleackley; Janet E McElhaney
Journal:  J Immunol Methods       Date:  2003-05-01       Impact factor: 2.303

6.  Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden.

Authors:  K G Nicholson; J Kent; V Hammersley; E Cancio
Journal:  BMJ       Date:  1997-10-25

7.  Assessment of markers of the cell-mediated immune response after influenza virus infection in frail older adults.

Authors:  J E McElhaney; S Gravenstein; P Krause; J W Hooton; C M Upshaw; P Drinka
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

9.  Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity.

Authors:  J E McElhaney; M J Pinkoski; C M Upshaw; R C Bleackley
Journal:  J Immunol Methods       Date:  1996-03-28       Impact factor: 2.303

View more
  42 in total

1.  GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.

Authors:  Hayedeh Behzad; Anke L W Huckriede; Laura Haynes; Beth Gentleman; Krysta Coyle; Jan C Wilschut; Tobias R Kollmann; Steven G Reed; Janet E McElhaney
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Mitch Phillips; Suzanne C Lechner; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

Review 3.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

4.  Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.

Authors:  Hugues de Lavallade; Paula Garland; Takuya Sekine; Katja Hoschler; David Marin; Kate Stringaris; Eva Loucaides; Katherine Howe; Richard Szydlo; Ed Kanfer; Donald Macdonald; Peter Kelleher; Nichola Cooper; Ahmad Khoder; Ian H Gabriel; Dragana Milojkovic; Jiri Pavlu; John M Goldman; Jane F Apperley; Katayoun Rezvani
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

5.  Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.

Authors:  Shahzma Merani; George A Kuchel; Alison Kleppinger; Janet E McElhaney
Journal:  Exp Gerontol       Date:  2017-09-27       Impact factor: 4.032

Review 6.  Fast vaccine design and development based on correlates of protection (COPs).

Authors:  Cécile van Els; Siri Mjaaland; Lisbeth Næss; Julia Sarkadi; Eva Gonczol; Karen Smith Korsholm; Jon Hansen; Jørgen de Jonge; Gideon Kersten; Jennifer Warner; Amanda Semper; Corine Kruiswijk; Fredrik Oftung
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison.

Authors:  Arun Kumar; Janet E McElhaney; Lisa Walrond; Terry D Cyr; Shahzma Merani; Tobias R Kollmann; Scott A Halperin; David W Scheifele
Journal:  Hum Vaccin Immunother       Date:  2017-06-21       Impact factor: 3.452

Review 8.  Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications.

Authors:  Melissa K Andrew; Susan K Bowles; Graham Pawelec; Laura Haynes; George A Kuchel; Shelly A McNeil; Janet E McElhaney
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

9.  Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults.

Authors:  Xu Yao; Robert G Hamilton; Nan-ping Weng; Qian-Li Xue; Jay H Bream; Huifen Li; Jing Tian; Shu-Hui Yeh; Barbara Resnick; Xiyan Xu; Jeremy Walston; Linda P Fried; Sean X Leng
Journal:  Vaccine       Date:  2011-05-10       Impact factor: 3.641

10.  B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.